# FONDAPARINUX SODIUM
> **ANDA218312** · Abbreviated New Drug Application (Generic) · Sponsor: BRIGHTGENE · Approved 2024-12-18
## Drug
- **FDA Application Number:** ANDA218312
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FONDAPARINUX SODIUM
- **Generic name:** Fondaparinux Sodium
- **Active ingredients:** FONDAPARINUX SODIUM
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** BRIGHTGENE
- **First approval:** 2024-12-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218312)
---
*MORVS · CC0 1.0*